A Safety, Tolerability and Efficacy Study of NC525 in Subjects With Advanced Myeloid Neoplasms

Clinical trial NCT05787496 · TERMINATED

Trial details

NCT number: NCT05787496
Sponsor: NextCure, Inc.
Status: TERMINATED
Phase: Phase 1
Study type: INTERVENTIONAL

Relapsed or Refractory Acute Myeloid Leukemia Relapsed or Refractory Chronic Myelomonocytic Leukemia Relapsed or Refractory Myelodysplastic Syndrome

Start date: 2023-02-28
Primary completion: 2025-01-31
Enrollment: 28

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.